Hangzhou Diagens Biotechnology Co., Ltd. (HKG:2526)
Hong Kong
· Delayed Price · Currency is HKD
271.00
+1.80 (0.67%)
At close: Apr 29, 2026
HKG:2526 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Net Income | - | -43.38 | -56.12 |
| Depreciation & Amortization | - | 13.63 | 7.51 |
| Loss (Gain) From Sale of Assets | - | -0.18 | 0.08 |
| Loss (Gain) From Sale of Investments | - | 2.07 | 1.01 |
| Loss (Gain) on Equity Investments | - | 0.1 | 0 |
| Stock-Based Compensation | - | 0.1 | 6.44 |
| Other Operating Activities | - | 19.2 | 14.85 |
| Change in Accounts Receivable | - | -28.09 | -1.02 |
| Change in Inventory | - | 4.2 | -2.44 |
| Change in Accounts Payable | - | 4.19 | -0.28 |
| Change in Other Net Operating Assets | - | -1.61 | -17.43 |
| Operating Cash Flow | - | -29.78 | -47.4 |
| Capital Expenditures | - | -24.2 | -24.22 |
| Sale of Property, Plant & Equipment | - | 0.24 | - |
| Sale (Purchase) of Intangibles | - | -1.05 | - |
| Investment in Securities | - | 23.66 | -92.84 |
| Other Investing Activities | - | 21 | - |
| Investing Cash Flow | - | 19.66 | -117.06 |
| Short-Term Debt Issued | - | 10 | - |
| Total Debt Issued | - | 10 | - |
| Long-Term Debt Repaid | - | -2.73 | -2.2 |
| Net Debt Issued (Repaid) | - | 7.28 | -2.2 |
| Issuance of Common Stock | - | - | 170.15 |
| Other Financing Activities | - | -0.47 | -3.97 |
| Financing Cash Flow | - | 6.81 | 163.98 |
| Net Cash Flow | - | -3.32 | -0.47 |
| Free Cash Flow | - | -53.98 | -71.61 |
| Free Cash Flow Margin | - | -76.72% | -135.52% |
| Free Cash Flow Per Share | - | -0.68 | -0.94 |
| Cash Interest Paid | - | 0.47 | 0.26 |
| Cash Income Tax Paid | - | 0.03 | - |
| Levered Free Cash Flow | - | -63.77 | - |
| Unlevered Free Cash Flow | - | -50.52 | - |
| Change in Working Capital | - | -21.31 | -21.17 |
Source: S&P Capital IQ. Standard template.
Financial Sources.